Center for Drug Evaluation and Research |
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL FIORICET >D> AB + NOVARTIS 325MG;50MG;40MG N88616 001 NOV 09, 1984 APR CAHN >A> AB + WATSON PHARMS 325MG;50MG;40MG N88616 001 NOV 09, 1984 APR CAHN ACYCLOVIR CAPSULE; ORAL ACYCLOVIR >A> AB AAIPHARMA 200MG N74833 001 APR 22, 1997 APR CAHN >D> AB AESGEN 200MG N74833 001 APR 22, 1997 APR CAHN ALBUTEROL SULFATE SOLUTION; INHALATION ALBUTEROL SULFATE >A> AN NOVEX EQ 0.5% BASE N76391 001 APR 01, 2003 APR NEWA ALMOTRIPTAN MALATE TABLET; ORAL AXERT >A> JANSSEN ORTHO EQ 6.25MG BASE N21001 001 MAY 07, 2001 APR CAHN >A> + EQ 12.5MG BASE N21001 002 MAY 07, 2001 APR CAHN >D> PHARMACIA AND UPJOHN EQ 6.25MG BASE N21001 001 MAY 07, 2001 APR CAHN >D> + EQ 12.5MG BASE N21001 002 MAY 07, 2001 APR CAHN AMANTADINE HYDROCHLORIDE CAPSULE; ORAL AMANTADINE HCL >A> AB GENEVA PHARMS 100MG N71293 001 FEB 18, 1987 APR CAHN >D> AB GENEVA PHARMS TECH 100MG N71293 001 FEB 18, 1987 APR CAHN AMCINONIDE CREAM; TOPICAL >A> AMCINONIDE >A> AT TARO PHARM INDS 0.1% N76229 001 MAY 31, 2002 APR NEWA CYCLOCORT >D> + FUJISAWA HLTHCARE 0.1% N18116 002 APR CFTG >A> AT + 0.1% N18116 002 APR CFTG AMIODARONE HYDROCHLORIDE INJECTABLE; INJECTION AMIODARONE HCL >A> AP APOTEX 50MG/ML N76394 001 APR 25, 2003 APR NEWA AMMONIUM LACTATE CREAM; TOPICAL AMMONIUM LACTATE >A> AB TARO EQ 12% BASE N75883 001 APR 10, 2003 APR NEWA AZELASTINE HYDROCHLORIDE SOLUTION/DROPS; OPHTHALMIC OPTIVAR >A> + MEDPOINTE 0.05% N21127 001 MAY 22, 2000 APR CAHN >D> + MURO 0.05% N21127 001 MAY 22, 2000 APR CAHN CARBINOXAMINE MALEATE >A> SOLUTION; ORAL >A> CARBINOXAMINE MALEATE >A> + MIKART 4MG/5ML N40458 001 APR 25, 2003 APR NEWA CARVEDILOL TABLET; ORAL COREG >D> GLAXOSMITHKLINE 12.5MG N20297 002 SEP 14, 1995 APR CRLD >A> + 12.5MG N20297 002 SEP 14, 1995 APR CRLD >D> + 25MG N20297 001 SEP 14, 1995 APR CRLD >A> 25MG N20297 001 SEP 14, 1995 APR CRLD >D> CEFIXIME >D> FOR SUSPENSION; ORAL >D> SUPRAX >D> + LEDERLE 100MG/5ML N50622 001 APR 28, 1989 APR DISC >A> @ 100MG/5ML N50622 001 APR 28, 1989 APR DISC >D> TABLET; ORAL >D> + LEDERLE 200MG N50621 001 APR 28, 1989 APR DISC >A> @ 200MG N50621 001 APR 28, 1989 APR DISC >D> + 400MG N50621 002 APR 28, 1989 APR DISC >A> @ 400MG N50621 002 APR 28, 1989 APR DISC CEFUROXIME AXETIL TABLET; ORAL CEFUROXIME AXETIL >A> AB RANBAXY EQ 125MG BASE N65118 001 APR 25, 2003 APR NEWA >A> AB EQ 250MG BASE N65118 002 APR 25, 2003 APR NEWA >A> AB EQ 500MG BASE N65118 003 APR 25, 2003 APR NEWA CLADRIBINE INJECTABLE; INJECTION LEUSTATIN >D> + ORTHO BIOTECH 1MG/ML N20229 001 FEB 26, 1993 APR CTEC >A> AP + 1MG/ML N20229 001 FEB 26, 1993 APR CTEC CLONAZEPAM TABLET, ORALLY DISINTEGRATING; ORAL KLONOPIN RAPIDLY DISINTEGRATING >D> @ ROCHE 0.125MG N20813 001 DEC 23, 1997 APR CMFD >A> 0.125MG N20813 001 DEC 23, 1997 APR CMFD >D> @ 0.25MG N20813 002 DEC 23, 1997 APR CMFD >A> 0.25MG N20813 002 DEC 23, 1997 APR CMFD >D> @ 0.5MG N20813 003 DEC 23, 1997 APR CMFD >A> 0.5MG N20813 003 DEC 23, 1997 APR CMFD >D> @ 1MG N20813 004 DEC 23, 1997 APR CMFD >A> + 1MG N20813 004 DEC 23, 1997 APR CMFD >D> @ 2MG N20813 005 DEC 23, 1997 APR CMFD >A> 2MG N20813 005 DEC 23, 1997 APR CMFD CORTISONE ACETATE TABLET; ORAL CORTISONE ACETATE >D> BP PHARMACIA AND UPJOHN 25MG N08126 001 APR CRLD >A> BP + 25MG N08126 001 APR CRLD >D> CORTONE >D> BP + MERCK 25MG N07750 003 APR DISC >A> @ 25MG N07750 003 APR DISC CYCLOBENZAPRINE HYDROCHLORIDE TABLET; ORAL FLEXERIL >D> AA MCNEIL CONS SPECLT 5MG N17821 001 APR CTEC >A> 5MG N17821 001 APR CTEC >A> DESIRUDIN >A> INJECTABLE; SUBCUTANEOUS >A> IPRIVASK >A> + AVENTIS PHARMS 15MG/VIAL N21271 001 APR 04, 2003 APR NEWA DEXAMETHASONE ELIXIR; ORAL >D> DECADRON >D> AA + MERCK 0.5MG/5ML N12376 002 APR DISC >A> @ 0.5MG/5ML N12376 002 APR DISC HEXADROL >D> AA ORGANON 0.5MG/5ML N12674 001 APR CRLD >A> AA + 0.5MG/5ML N12674 001 APR CRLD DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE; INJECTION DEXAMETHASONE SODIUM PHOSPHATE >A> AP AM PHARM EQ 10MG PHOSPHATE/ML N40491 001 APR 11, 2003 APR NEWA DIHYDROERGOTAMINE MESYLATE INJECTABLE; INJECTION D.H.E. 45 >D> XCEL PHARMS 1MG/ML N05929 001 APR CFTG >A> AP + 1MG/ML N05929 001 APR CFTG >A> DIHYDROEROGTAMINE MESYLATE >A> AP PADDOCK 1MG/ML N40475 001 APR 28, 2003 APR NEWA DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE; ORAL >A> TAZTIA XT >A> AB4 ANDRX PHARMS 120MG N75401 001 APR 10, 2003 APR NEWA >A> AB4 180MG N75401 002 APR 10, 2003 APR NEWA >A> AB4 240MG N75401 003 APR 10, 2003 APR NEWA >A> AB4 300MG N75401 004 APR 10, 2003 APR NEWA >A> AB4 360MG N75401 005 APR 10, 2003 APR NEWA TIAZAC >D> BC + BIOVAIL 120MG N20401 001 SEP 11, 1995 APR CFTG >A> AB4 + 120MG N20401 001 SEP 11, 1995 APR CFTG >D> BC + 180MG N20401 002 SEP 11, 1995 APR CFTG >A> AB4 + 180MG N20401 002 SEP 11, 1995 APR CFTG >D> BC + 240MG N20401 003 SEP 11, 1995 APR CFTG >A> AB4 + 240MG N20401 003 SEP 11, 1995 APR CFTG >D> BC + 300MG N20401 004 SEP 11, 1995 APR CFTG >A> AB4 + 300MG N20401 004 SEP 11, 1995 APR CFTG >D> + 360MG N20401 005 SEP 11, 1995 APR CFTG >A> AB4 + 360MG N20401 005 SEP 11, 1995 APR CFTG ERYTHROMYCIN SOLUTION; TOPICAL STATICIN >D> AT + WESTWOOD SQUIBB 1.5% N50526 001 APR CTEC >A> + 1.5% N50526 001 APR CTEC ETHINYL ESTRADIOL; LEVONORGESTREL TABLET; ORAL-21 LEVONORGESTREL AND ETHINYL ESTRADIOL >A> AB1 BARR 0.02MG;0.1MG N75862 001 APR 29, 2003 APR NEWA TABLET; ORAL-28 >A> AB1 BARR 0.02MG;0.1MG N75862 002 APR 29, 2003 APR NEWA ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET; ORAL-21 ESTROSTEP 21 >A> @ GALEN CHEM 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG N20130 001 OCT 09, 1996 APR CAHN >D> @ PARKE DAVIS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG N20130 001 OCT 09, 1996 APR CAHN LOESTRIN 21 1.5/30 >A> + GALEN CHEM 0.03MG;1.5MG N17875 001 APR CAHN >D> + PARKE DAVIS 0.03MG;1.5MG N17875 001 APR CAHN LOESTRIN 21 1/20 >A> + GALEN CHEM 0.02MG;1MG N17876 001 APR CAHN >D> + PARKE DAVIS 0.02MG;1MG N17876 001 APR CAHN TABLET; ORAL-28 ESTROSTEP FE >A> + GALEN CHEM 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG N20130 002 OCT 09, 1996 APR CAHN >D> + PARKE DAVIS 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG N20130 002 OCT 09, 1996 APR CAHN LOESTRIN FE 1.5/30 >A> AB + GALEN CHEM 0.03MG;1.5MG N17355 001 APR CAHN >D> AB + PARKE DAVIS 0.03MG;1.5MG N17355 001 APR CAHN LOESTRIN FE 1/20 >A> AB + GALEN CHEM 0.02MG;1MG N17354 001 APR CAHN >D> AB + PARKE DAVIS 0.02MG;1MG N17354 001 APR CAHN FLUVOXAMINE MALEATE TABLET; ORAL FLUVOXAMINE MALEATE >A> AB GENEVA PHARMS 25MG N75887 001 JAN 05, 2001 APR CAHN >A> AB 50MG N75887 002 JAN 05, 2001 APR CAHN >A> AB 100MG N75887 003 JAN 05, 2001 APR CAHN >D> AB INVAMED 25MG N75887 001 JAN 05, 2001 APR CAHN >D> AB 50MG N75887 002 JAN 05, 2001 APR CAHN >D> AB 100MG N75887 003 JAN 05, 2001 APR CAHN GALANTAMINE HYDROBROMIDE TABLET; ORAL REMINYL >D> JANSSEN PHARMA EQ 4MG BASE N21169 001 FEB 28, 2001 APR CRLD >A> + EQ 4MG BASE N21169 001 FEB 28, 2001 APR CRLD >D> + EQ 12MG BASE N21169 003 FEB 28, 2001 APR CRLD >A> EQ 12MG BASE N21169 003 FEB 28, 2001 APR CRLD GATIFLOXACIN INJECTABLE; INJECTION TEQUIN >D> BRISTOL MYERS SQUIBB EQ 2MG /ML(200MG/100ML) N21062 001 DEC 17, 1999 APR CRLD >D> EQ 2MG /ML(400MG/200ML) N21062 002 DEC 17, 1999 APR CRLD >A> + EQ 2MG /ML(200MG/100ML) N21062 001 DEC 17, 1999 APR CRLD >A> + EQ 2MG /ML(400MG/200ML) N21062 002 DEC 17, 1999 APR CRLD >D> EQ 10MG /ML(200MG) N21062 003 DEC 17, 1999 APR CRLD >A> + EQ 10MG /ML(200MG) N21062 003 DEC 17, 1999 APR CRLD >A> GEMIFLOXACIN MESYLATE >A> TABLET; ORAL >A> FACTIVE >A> + LG LIFE EQ 320MG BASE N21158 001 APR 04, 2003 APR NEWA GENTAMICIN SULFATE OINTMENT; OPHTHALMIC >D> GARAMYCIN >D> AT + SCHERING EQ 0.3% BASE N50425 001 APR DISC >A> @ EQ 0.3% BASE N50425 001 APR DISC GENTAMICIN SULFATE >D> AT AKORN EQ 0.3% BASE N64093 001 AUG 31, 1995 APR CRLD >A> + EQ 0.3% BASE N64093 001 AUG 31, 1995 APR CRLD HYDROCODONE BITARTRATE; IBUPROFEN TABLET; ORAL >A> HYDROCODONE BITARTRATE AND IBUPROFEN >A> AB TEVA 7.5MG;200MG N76023 001 APR 11, 2003 APR NEWA VICOPROFEN >D> + ABBOTT 7.5MG;200MG N20716 001 SEP 23, 1997 APR CFTG >A> AB + 7.5MG;200MG N20716 001 SEP 23, 1997 APR CFTG >D> HYDROCORTISONE SODIUM PHOSPHATE >D> INJECTABLE; INJECTION >D> HYDROCORTONE >D> + MERCK EQ 50MG BASE/ML N12052 001 APR DISC >A> @ EQ 50MG BASE/ML N12052 001 APR DISC HYDROMORPHONE HYDROCHLORIDE INJECTABLE; INJECTION HYDROMORPHONE HCL >A> AP FAULDING 10MG/ML N76444 001 APR 25, 2003 APR NEWA IMATINIB MESYLATE >A> TABLET; ORAL >A> GLEEVEC >A> NOVARTIS 100MG N21588 001 APR 18, 2003 APR NEWA >A> + 400MG N21588 002 APR 18, 2003 APR NEWA IPRATROPIUM BROMIDE SPRAY, METERED; NASAL IPRATROPIUM BROMIDE >A> AB NOVEX 0.021MG/SPRAY N76156 001 APR 18, 2003 APR NEWA >A> AB 0.042MG/SPRAY N76155 001 APR 18, 2003 APR NEWA ISOTRETINOIN CAPSULE; ORAL CLARAVIS >A> AB BARR 10MG N76356 001 APR 11, 2003 APR NEWA >A> AB 20MG N76135 002 APR 11, 2003 APR NEWA >A> AB 40MG N76135 001 APR 11, 2003 APR NEWA LEVOTHYROXINE SODIUM TABLET; ORAL LEVO-T >A> BX ALARA PHARM 0.025MG N21342 001 MAR 01, 2002 APR CAHN >A> BX 0.05MG N21342 002 MAR 01, 2002 APR CAHN >A> BX 0.075MG N21342 003 MAR 01, 2002 APR CAHN >A> BX 0.088MG N21342 004 MAR 01, 2002 APR CAHN >A> BX 0.1MG N21342 005 MAR 01, 2002 APR CAHN >A> BX 0.112MG N21342 006 MAR 01, 2002 APR CAHN >A> BX 0.125MG N21342 007 MAR 01, 2002 APR CAHN >A> BX 0.15MG N21342 008 MAR 01, 2002 APR CAHN >A> BX 0.175MG N21342 009 MAR 01, 2002 APR CAHN >A> BX 0.2MG N21342 010 MAR 01, 2002 APR CAHN >A> BX + 0.3MG N21342 011 MAR 01, 2002 APR CAHN >D> BX MOVA 0.025MG N21342 001 MAR 01, 2002 APR CAHN >D> BX 0.05MG N21342 002 MAR 01, 2002 APR CAHN >D> BX 0.075MG N21342 003 MAR 01, 2002 APR CAHN >D> BX 0.088MG N21342 004 MAR 01, 2002 APR CAHN >D> BX 0.1MG N21342 005 MAR 01, 2002 APR CAHN >D> BX 0.112MG N21342 006 MAR 01, 2002 APR CAHN >D> BX 0.125MG N21342 007 MAR 01, 2002 APR CAHN >D> BX 0.15MG N21342 008 MAR 01, 2002 APR CAHN >D> BX 0.175MG N21342 009 MAR 01, 2002 APR CAHN >D> BX 0.2MG N21342 010 MAR 01, 2002 APR CAHN >D> BX + 0.3MG N21342 011 MAR 01, 2002 APR CAHN LISINOPRIL TABLET; ORAL ZESTRIL >D> AB + ASTRAZENECA 30MG N19777 006 JAN 20, 1999 APR CRLD >A> AB 30MG N19777 006 JAN 20, 1999 APR CRLD LITHIUM CARBONATE TABLET, EXTENDED RELEASE; ORAL LITHIUM CARBONATE >A> AB ABLE 300MG N76382 001 APR 21, 2003 APR NEWA MECAMYLAMINE HYDROCHLORIDE TABLET; ORAL INVERSINE >D> + LAYTON 2.5MG N10251 001 APR CAHN >A> + TARGACEPT 2.5MG N10251 001 APR CAHN MEFLOQUINE HYDROCHLORIDE TABLET; ORAL MEFLOQUINE HCL >A> AB GENEVA PHARMS 250MG N76175 001 FEB 20, 2002 APR CAHN >D> AB GENEVA PHARMS TECH 250MG N76175 001 FEB 20, 2002 APR CAHN MEPROBAMATE TABLET; ORAL MILTOWN >A> AA + MEDPOINTE 600MG N83919 001 APR CAHN >D> AA + WALLACE PHARMS 600MG N83919 001 APR CAHN METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL GLUCOPHAGE XR >A> + BRISTOL MYERS SQUIBB 750MG N21202 004 APR 11, 2003 APR NEWA METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE TABLET; ORAL AVANDAMET >D> GLAXOSMITHKLINE 500MG;EQ 1MG BASE N21410 001 OCT 10, 2002 APR CAHN >D> 500MG;EQ 2MG BASE N21410 002 OCT 10, 2002 APR CAHN >D> + 500MG;EQ 4MG BASE N21410 003 OCT 10, 2002 APR CAHN >A> SB PHARMCO 500MG;EQ 1MG BASE N21410 001 OCT 10, 2002 APR CAHN >A> + 500MG;EQ 4MG BASE N21410 003 OCT 10, 2002 APR CAHN >A> 500MG;EQ 2MG BASE N21410 002 OCT 10, 2002 APR CAHN METHADONE HYDROCHLORIDE INJECTABLE; INJECTION DOLOPHINE HCL >A> + AAIPHARMA 10MG/ML N21624 001 APR CAHN >D> + ROXANE 10MG/ML N21624 001 APR CAHN METHYLPHENIDATE HYDROCHLORIDE >A> TABLET, CHEWABLE; ORAL >A> METHYLIN >A> MALLINCKRODT 2.5MG N21475 001 APR 15, 2003 APR NEWA >A> 5MG N21475 002 APR 15, 2003 APR NEWA >A> + 10MG N21475 003 APR 15, 2003 APR NEWA METOCLOPRAMIDE HYDROCHLORIDE SOLUTION; ORAL METOCLOPRAMIDE >D> AA UDL EQ 5MG BASE/5ML N75051 001 JAN 26, 2001 APR CAHN >A> AA VISTAPHARM EQ 5MG BASE/5ML N75051 001 JAN 26, 2001 APR CAHN MINOCYCLINE HYDROCHLORIDE >A> TABLET; ORAL >A> MINOCYCLINE HCL >A> PAR PHARM EQ 50MG BASE N65131 001 APR 16, 2003 APR NEWA >A> EQ 75MG BASE N65131 002 APR 16, 2003 APR NEWA >A> + EQ 100MG BASE N65131 003 APR 16, 2003 APR NEWA MOXIFLOXACIN HYDROCHLORIDE >A> SOLUTION/DROPS; OPHTHALMIC >A> VIGAMOX >A> + ALCON 0.5% N21598 001 APR 15, 2003 APR NEWA MUPIROCIN OINTMENT; TOPICAL MUPIROCIN >D> BX CLAY PARK LABS 2% N50788 001 DEC 04, 2002 APR CAHN >A> BX JOHNSON AND JOHNSON 2% N50788 001 DEC 04, 2002 APR CAHN NAPROXEN SODIUM TABLET, EXTENDED RELEASE; ORAL NAPRELAN >D> + ELAN PHARM EQ 375MG BASE N20353 001 JAN 05, 1996 APR CFTG >A> AB + EQ 375MG BASE N20353 001 JAN 05, 1996 APR CFTG >A> NAPROXEN SODIUM >A> AB ANDRX PHARMS EQ 375MG BASE N75416 002 APR 23, 2003 APR NEWA NELFINAVIR MESYLATE TABLET; ORAL VIRACEPT >A> + AGOURON EQ 625MG BASE N21503 001 APR 30, 2003 APR NEWA NITROFURANTOIN >D> TABLET; ORAL >D> FURADANTIN >D> AB PROCTER AND GAMBLE 50MG N08693 001 APR DISC >A> @ 50MG N08693 001 APR DISC >D> AB + 100MG N08693 002 APR DISC >A> @ 100MG N08693 002 APR DISC >D> NITROFURANTOIN >D> AB WATSON LAB 50MG N80447 001 APR DISC >A> @ 50MG N80447 001 APR DISC >D> AB WHITEWORTH TOWN PLSN 100MG N84085 002 APR DISC >A> @ 100MG N84085 002 APR DISC NITROGLYCERIN FILM, EXTENDED RELEASE; TRANSDERMAL NITROGLYCERIN >D> AB2 MYLAN 0.1MG/HR N75033 001 FEB 06, 1998 APR CAHN >D> AB2 0.2MG/HR N74609 001 AUG 30, 1996 APR CAHN >D> AB2 0.4MG/HR N74607 001 AUG 30, 1996 APR CAHN >D> AB2 0.6MG/HR N74559 001 AUG 30, 1996 APR CAHN >A> AB2 MYLAN TECHNOLOGIES 0.1MG/HR N75033 001 FEB 06, 1998 APR CAHN >A> AB2 0.2MG/HR N74609 001 AUG 30, 1996 APR CAHN >A> AB2 0.4MG/HR N74607 001 AUG 30, 1996 APR CAHN >A> AB2 0.6MG/HR N74559 001 AUG 30, 1996 APR CAHN OINTMENT; TRANSDERMAL >D> + ALTANA 2% N87355 001 JUL 08, 1988 APR CAHN >A> + FOUGERA 2% N87355 001 JUL 08, 1988 APR CAHN PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE; ORAL PROTONIX >D> + WYETH PHARMS INC EQ 20MG BASE N20987 002 JUN 12, 2001 APR CRLD >A> EQ 20MG BASE N20987 002 JUN 12, 2001 APR CRLD PERMETHRIN CREAM; TOPICAL PERMETHRIN >A> AB CLAY PARK 5% N76369 001 APR 21, 2003 APR NEWA PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP; ORAL >D> PHENERGAN VC >D> AA + WYETH AYERST 5MG/5ML;6.25MG/5ML N08604 003 APR 02, 1984 APR DISC >A> @ 5MG/5ML;6.25MG/5ML N08604 003 APR 02, 1984 APR DISC PROMETH VC PLAIN >D> AA ALPHARMA 5MG/5ML;6.25MG/5ML N88761 001 NOV 08, 1984 APR CRLD >A> AA + 5MG/5ML;6.25MG/5ML N88761 001 NOV 08, 1984 APR CRLD PILOCARPINE HYDROCHLORIDE TABLET; ORAL SALAGEN >D> + MGI PHARMA INC 5MG N20237 001 MAR 22, 1994 APR CRLD >A> 5MG N20237 001 MAR 22, 1994 APR CRLD >A> + 7.5MG N20237 002 APR 18, 2003 APR NEWA PREDNICARBATE CREAM; TOPICAL DERMATOP E EMOLLIENT >D> + DERMIK LABS 0.1% N20279 001 OCT 29, 1993 APR CTNA >A> + 0.1% N20279 001 OCT 29, 1993 APR CTNA PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM SOLUTION/DROPS; OPHTHALMIC SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE >A> AT ALCON EQ 0.23% PHOSPHATE;10% N73630 001 MAY 27, 1993 APR CAHN >D> AT ALCON UNIVERSAL EQ 0.23% PHOSPHATE;10% N73630 001 MAY 27, 1993 APR CAHN PROMETHAZINE HYDROCHLORIDE INJECTABLE; INJECTION >D> PHENERGAN >D> AP + WYETH AYERST 50MG/ML N08857 003 APR DISC >A> @ 50MG/ML N08857 003 APR DISC PROMETHAZINE HCL >D> AP GENSIA SICOR PHARMS 25MG/ML N40454 001 AUG 22, 2002 APR CRLD >A> AP + 25MG/ML N40454 001 AUG 22, 2002 APR CRLD >D> AP 50MG/ML N40454 002 AUG 22, 2002 APR CRLD >A> AP + 50MG/ML N40454 002 AUG 22, 2002 APR CRLD SUPPOSITORY; RECTAL >A> AB ABLE 12.5MG N40504 001 APR 11, 2003 APR NEWA >A> AB 25MG N40504 002 APR 11, 2003 APR NEWA PYRIDOSTIGMINE BROMIDE TABLET; ORAL PYRIDOSTIGMINE BROMIDE >A> AB IMPAX LABS 60MG N40502 001 APR 24, 2003 APR NEWA QUINIDINE GLUCONATE TABLET, EXTENDED RELEASE; ORAL QUINIDINE GLUCONATE >D> BX MUTUAL PHARM 324MG N89338 001 FEB 11, 1987 APR CRLD >A> BX + 324MG N89338 001 FEB 11, 1987 APR CRLD >D> + WATSON LABS 324MG N87810 001 SEP 29, 1982 APR CRLD >A> BX 324MG N87810 001 SEP 29, 1982 APR CRLD RISPERIDONE >A> TABLET, ORALLY DISINTEGRATING; ORAL >A> RISPERDAL >A> JOHNSON AND JOHNSON 0.5MG N21444 001 APR 02, 2003 APR NEWA >A> + 1MG N21444 002 APR 02, 2003 APR NEWA >A> 2MG N21444 003 APR 02, 2003 APR NEWA ROSIGLITAZONE MALEATE TABLET; ORAL AVANDIA >D> GLAXOSMITHKLINE EQ 2MG BASE N21071 002 MAY 25, 1999 APR CAHN >D> EQ 4MG BASE N21071 003 MAY 25, 1999 APR CAHN >D> + EQ 8MG BASE N21071 004 MAY 25, 1999 APR CAHN >A> SB PHARMCO EQ 2MG BASE N21071 002 MAY 25, 1999 APR CAHN >A> EQ 4MG BASE N21071 003 MAY 25, 1999 APR CAHN >A> + EQ 8MG BASE N21071 004 MAY 25, 1999 APR CAHN SEVELAMER HYDROCHLORIDE CAPSULE; ORAL RENAGEL >D> + GELTEX 403MG N20926 001 OCT 30, 1998 APR CAHN >A> + GENZYME 403MG N20926 001 OCT 30, 1998 APR CAHN TABLET; ORAL >D> GELTEX 400MG N21179 001 JUL 12, 2000 APR CAHN >D> + 800MG N21179 002 JUL 12, 2000 APR CAHN >A> GENZYME 400MG N21179 001 JUL 12, 2000 APR CAHN >A> + 800MG N21179 002 JUL 12, 2000 APR CAHN SOTALOL HYDROCHLORIDE TABLET; ORAL BETAPACE AF >A> BERLEX LABS 40MG N21151 006 APR 02, 2003 APR NEWA >A> 60MG N21151 007 APR 02, 2003 APR NEWA TAMOXIFEN CITRATE TABLET; ORAL TAMOXIFEN CITRATE >A> AB PHARMACHEMIE EQ 10MG BASE N74539 001 MAR 31, 2003 APR CAHN >A> AB TEVA EQ 10MG BASE N74504 001 APR 28, 2003 APR NEWA >D> AB EQ 10MG BASE N74539 001 MAR 31, 2003 APR CAHN >A> AB EQ 20MG BASE N74504 002 APR 28, 2003 APR NEWA TESTOSTERONE GEL; TOPICAL ANDROGEL >D> + UNIMED PHARMS 1% N21015 001 FEB 28, 2000 APR CTEC >A> BX + 1% N21015 001 FEB 28, 2000 APR CTEC TESTIM >D> + AUXILIUM A2 1% N21454 001 OCT 31, 2002 APR CTEC >A> BX + 1% N21454 001 OCT 31, 2002 APR CTEC TIZANIDINE HYDROCHLORIDE TABLET; ORAL TIZANIDINE HCL >A> AB BARR EQ 2MG BASE N76371 001 APR 09, 2003 APR NEWA >A> AB EQ 4MG BASE N76371 002 APR 09, 2003 APR NEWA TRIAMCINOLONE ACETONIDE LOTION; TOPICAL TRIAMCINOLONE ACETONIDE >A> AT ALTANA 0.025% N40467 001 APR 21, 2003 APR NEWA >A> AT 0.1% N40467 002 APR 21, 2003 APR NEWA
LORATADINE SYRUP; ORAL CLARITIN >D> SCHERING 1MG/ML N20641 002 NOV 27, 2002 APR CRLD >A> + 1MG/ML N20641 002 NOV 27, 2002 APR CRLD TABLET; ORAL >D> SCHERING 10MG N19658 002 NOV 27, 2002 APR CRLD >A> + 10MG N19658 002 NOV 27, 2002 APR CRLD TABLET, ORALLY DISINTEGRATING; ORAL ALAVERT >D> + WYETH CONS 10MG N21375 001 DEC 19, 2002 APR CRLD >A> 10MG N21375 001 DEC 19, 2002 APR CRLD CLARITIN REDITABS >D> SCHERING 10MG N20704 002 NOV 27, 2002 APR CRLD >A> + 10MG N20704 002 NOV 27, 2002 APR CRLD LORATADINE; PSEUDOEPHEDRINE SULFATE TABLET, EXTENDED RELEASE; ORAL CLARITIN-D >D> SCHERING 5MG;120MG N19670 002 NOV 27, 2002 APR CRLD >A> + 5MG;120MG N19670 002 NOV 27, 2002 APR CRLD CLARITIN-D 24 HOUR >D> SCHERING 10MG;240MG N20470 002 NOV 27, 2002 APR CRLD >A> + 10MG;240MG N20470 002 NOV 27, 2002 APR CRLD
Back to Top Product List Archive
FDA/Center for Drug Evaluation and Research
Last Updated: March 18, 2003
Originator: OIT/DDMS
HTML by PKS